Associations between DPP-4 inhibitor use and suicidal behaviors were similar to those obtained for GLP-1 RA, including after stratification according to the presence or absence of a recent psychiatric history and obesity (Fig. 3 and Supplementary Table S4). The gene discussed is DPP4; the disease is obesity disorder.